About Gene expression analysis
Gene expression analysis studies the activity of the formation of a gene product from its coding gene. It is an indicator of biological activity of changing gene expression pattern, this is a widely used the approach in research, clinical and pharmaceutical to understand individual gene. It is the study of gene products by imaging, amplification, probe hybridization or sequencing-based detection methods. Gene expression is the method to extract information from a genetic material that can be exploited for the assembly of a functional gene product. With the help of gene expression, the genetic code on a DNA can be studied.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 10.13% |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Gene expression analysis market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Illumina Inc. (United States), Thermo Fisher Scientific (United States), Bio-Rad Laboratories (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Ge Healthcare (United States), Pacific Biosciences of California (Unites States), Bgi (Denmark), Perkinelmer (United States), Agilent Technologies Inc. (United States) and Qiagen N.V (Germany) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Gene expression analysis market by Type (Consumables (Reagents, DNA Chips) and Instruments (PCR, NGS, Microarray)), Application (Diagnostics, Pharmacogenomics, Toxicology and Compare Expression Levels of One or More Genes from Biomarkers) and Region.
On the basis of geography, the market of Gene expression analysis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Techniques Types, the sub-segment i.e. Absolute Quantitation Techniques (Serial Analysis of Gene Expression) will boost the Gene expression analysis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Service Types, the sub-segment i.e. Gene Expression Profiling Services will boost the Gene expression analysis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Real-Time PCR Has Risen As the Most Popularly Used Approach in Studies
Market Growth Drivers:
Decreasing Cost of Sequencing, High Availability of Gene Expression Databases and Growing Application Areas of Genomics
Challenges:
Lack of Skilled Labor Is Become Hurdle For Innovations in Firm
Restraints:
High Cost of Instrument Will Lead To Decline the Market
Opportunities:
Strong Requirement in High Volume of Research Studies Involving Gene Expression Analysis
Market Leaders and their expansionary development strategies
In February 17, 2024, XOMA Corp. acquires Kinnate Biopharma, a US-based cancer drug developer, for an undisclosed amount. This deal doesn't directly focus on gene expression analysis but could potentially involve related technologies used in drug development.
In January 10, 2024, NanoString Technologies launches the GeoMx DSP spatial molecular imager. This new product allows researchers to visualize gene expression at the single-cell level within tissues, providing a deeper understanding of complex biological processes.
Key Target Audience
Pharma and Biotech Companies and Research Centers
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.